About Us

Contact Us

Global Headquarters
Schering-Plough Corporation World Headquarters
2000 Galloping Hill Road
Kenilworth, N.J. 07033-0530
United States

Telephone: +1 (908) 298-4000

Directions to our New Jersey locations

Partnerships

In today's competitive pharmaceutical industry, strategic licensing agreements and partnerships are key to maintaining a balanced portfolio of products and technologies. To partner with us, please contact a representative in one of the following areas:

Human Prescription	Consumer Health Care
Animal Health	Mergers & Acquisitions

Growing Stronger, Growing Better

Our combination with Organon BioSciences is a transformational step on Schering-Plough’s continuing journey as we build a high-performance company for the long term.

Basic Facts & Figures

World Headquarters
2000 Galloping Hill Road, Kenilworth, N.J. 07033-0530

Chairman and CEO
Fred Hassan

Number of employees
51,000

Net sales (2008)
$18.5 billion

Business Operations in
more than 140 countries

Largest-selling products
VYTORIN*, ZETIA*, REMICADE, NASONEX, TEMODAR

R&D investment (2008)
$3.5 billion

Areas of research
cardiovascular disease, central nervous system disorders, immunology and infectious disease, oncology, respiratory diseases and women's health

*VYTORIN and ZETIA are managed through a joint venture with Merck & Co., Inc. Schering-Plough accounts for the joint venture under the Equity method. Total cholesterol joint venture sales were $4.5 billion in 2008.

Schering-Plough Worldwide

Schering-Plough has subsidiaries in more than 55 countries outside of the United States

Choose your continent from the map below or use the navigation at left to locate your country's contact details.

Schering-Plough Corporation